Phenylephrine infusion for prevention of hypotension during spinal anesthesia for elective cesarean section

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs041190070

Enrollment

Registered

2019-09-25

Start date

2019-10-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

elective caesarean section

Interventions

All participants are divided into two groups, phenylephrine group and conventional group. In phenylephrine group, at the same time of spinal anesthesia, starting preventive infusion of phenylephrine 0

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1.elective caesarean section under spinal anesthesia 2.age over 20 years old 3.written informed consent

Exclusion criteria

Exclusion criteria: 1.cannot communicate 2.patients complicated with hypertension, heart and vessel disease, diabetes 3.multiple pregnancy, excessive amniotic fluid, fetal stunt 4.patients whose BMI >35 5.patients who are considered to be inappropriate

Design outcomes

Primary

Measure	Time frame
Occurrence of hypotension	—

Secondary

Measure	Time frame
Heart rate variability, total dose of phenylephrine, occurrence of nausea or/and vomiting, occurrence of bradycardia, apgar score, PH BE of umbilical cord blood gas	—

Contacts

Public ContactDaiki Nakashima

Gifu University Hospital

isi_m2001046@yahoo.co.jp+81-58-230-6404

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026